The US life sciences sector saw a flurry of merger and acquisition activity at the end of 2013, and it may continue into early 2014, according to an analysis from PricewaterhouseCoopers.

Overall, 2013 saw a contraction of 13 percent in medtech sector M&A, with a total of 41 deals, but a surge of 15 deals worth a collective $4.77 billion in the fourth quarter "may signal a healthy turn for the industry," MassDevice reports.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.